Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    2-[2-(2,6-dichloroanilino)phenyl]acetic acid.

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 32Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Over 160 Drug Samples Found Sub-Standard In December
    Over 160 Drug Samples Found Sub-Standard In December

    21 Jan 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/over-160-drug-samples-found-sub-standard-in-december/articleshow/127042008.cms

    ECONOMICTIMES
    21 Jan 2026
    Share Share
    Enforcement Report - Week of June 25, 2025
    Enforcement Report - Week of June 25, 2025

    25 Jun 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-25-2025-9500.pdf

    FDA
    25 Jun 2025
    Share Share
    Umary Issues a Nationwide Recall of Unavy Acidio Hialuronico
    Umary Issues a Nationwide Recall of Unavy Acidio Hialuronico

    22 May 2025

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/umary-usacom-issues-voluntary-nationwide-recall-unavy-acido-hialuronico-caplets-and-umovy-acido

    FDA
    22 May 2025
    Share Share
    Enforcement Report - Week of January 8, 2025
    Enforcement Report - Week of January 8, 2025

    08 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-8-2025-53657.pdf

    FDA
    08 Jan 2025
    Share Share
    GNMART Inc Issues Voluntary Nationwide Recall of Force Forever
    GNMART Inc Issues Voluntary Nationwide Recall of Force Forever

    16 Dec 2024

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gnmart-inc-issues-voluntary-nationwide-recall-force-forever-due-undeclared-drug-ingredients

    FDA
    16 Dec 2024
    Share Share
    Enforcement Report - Week of December 11, 2024
    Enforcement Report - Week of December 11, 2024

    11 Dec 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-11-2024-90405.pdf

    FDA
    11 Dec 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.